SecBot SecBot
6-K ·Filed Oct 20, 2026

LKFT

Lakefront Biotherapeutics NV
NEUTRAL
Impact 2/10
Horizonweeks Processed6d 11h ago SEC0001171843-26-006723
Notable filing: 6-K
Actionable Insight • Neutral

Buyback completion is a non-event for traders. Monitor upcoming quarterly results for pipeline updates on gamgertamig, the key value driver.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+1d
LKFT ▲ +2.68% at T+1d
NEUTRAL call +2.68% · α vs SPY +3.86% · entry $30.58 → $31.40
Next anchor: T+5d in 4h
Latest observation: T+2 +3.09% FF3 residual α
Entry = T+0 close
Oct 20, 2026
via day close
T+1d
+2.68%
call +2.68% · α +3.86%
$31.40
settled 6d ago
T+5d
Pending
in 4h
T+20d
Pending
in 21d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Lakefront Biotherapeutics completed its share repurchase program, buying back 107,804 shares for ~€2.85 million between October 12–16, 2026. The program, announced June 9, 2026, is now fully executed, with the company holding 1,985,157 treasury shares. This is a routine capital return update with no material financial impact.

Key Facts

  • Repurchased 107,804 shares at an average price of €26.48 per share, total consideration ~€2.85 million.
  • Repurchase program announced June 9, 2026, is now fully completed.
  • As of October 16, 2026, Lakefront holds 1,985,157 of its own ordinary shares.
  • Purchases were executed across XAMS, CEUX, AQEU, and TQEX markets via a discretionary mandate.

Financial Impact

~€2.85 million total spent on share repurchases, representing a small fraction of market cap.

shares outstandingtreasury shares

Risk Factors

  • No new financial or operational guidance provided.
  • Clinical-stage biotech with no approved products; pipeline execution risk remains.

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-006723
Document: f6k_102026.htm0001171843-26-006723
Document: 0001171843-26-006723-index-headers.html0001171843-26-006723
Document: 0001171843-26-006723-index.html0001171843-26-006723
Document: 0001171843-26-006723.txt0001171843-26-006723
11 reports for LKFT
Performance horizon
Filters
Rows
Reports for LKFT — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
6-K
NEUTRAL ★ 2/10
$30.58awaiting T+20—$31.69 (+3.63%)
Oct 14, 2026
12d ago
6-K
NEUTRAL ★ 4/10
$29.93awaiting T+20—$31.69 (+5.88%)
Oct 13, 2026
13d ago
6-K
NEUTRAL ★ 2/10
$29.40awaiting T+20—$31.69 (+7.79%)
Oct 6, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$30.00awaiting T+20—$31.69 (+5.63%)
Sep 1, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$28.81 $29.65▲ +2.92%▲ +3.25%$31.69 (+10.00%)
Aug 25, 2026
8w ago
6-K
NEUTRAL ★ 4/10
$29.70 $30.72▲ +3.43%▲ +2.46%$31.69 (+6.70%)
Aug 12, 2026
10w ago
6-K
MIXED ★ 6/10
$27.93 $26.81▼ −4.01%▼ −2.11%$31.69 (+13.46%)
Jul 28, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$27.72 $29.16▲ +5.19%▲ +0.17%$31.69 (+14.32%)
Jun 30, 2026
16w ago
6-K
NEUTRAL ★ 2/10
$29.60 $27.72▼ −6.35%▼ −4.17%$31.69 (+7.06%)
Jun 24, 2026
17w ago
6-K
NEUTRAL ★ 3/10
$29.01 $28.78▼ −0.79%▼ −2.73%$31.69 (+9.24%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 5h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 20, 2026